<DOC>
	<DOCNO>NCT02463110</DOCNO>
	<brief_summary>Primary purpose : To evaluate evolution time antiaggregant platelet effect sertraline ( SSRI ) compare placebo depressive patient ACS ( Acute Coronary Syndrome ) treat recommend double antiplatelet therapy , aspirin clopidogrel . Hypothesis : The benefit SSRIs observe depressive patient ACS related antiplatelet effect .</brief_summary>
	<brief_title>Acute Myocardial Necrosis Depression : Antiplatelet Effect Reuptake Inhibition Serotonin</brief_title>
	<detailed_description>Rational : 40 % patient hospitalize acute coronary syndrome ( ACS ) present depressive symptom . The increase cardiovascular morbidity mortality 6 month ( hazard ratio = 3.5 ) could partly explain alteration platelet parameter patient depression . Sertraline potent inhibitor selective serotonin reuptake ( SSRI ) . At platelet level , decrease secretion induce collagen cause inhibition serotonin reuptake platelet activation , wide simple anti-serotonergic effect . Its efficacy depression patient ACS demonstrate ( -20 % ischemic event 24 week vs placebo ) , partly independent correction depressive symptom , wide safety action . Antiplatelet , anti-inflammatory endothelial function effect sertraline demonstrate healthy volunteer , stable patient patient heart failure , never explore ACS . Multicenter , randomize , double-blind , control trial compare SSRI placebo depressive patient ACS . A control ( non depressive ) ACS group also clinical laboratory follow-up time ( without drug administration ) , constitute reference platelet parameter allow comparison depressive ACS group treat placebo . Randomization initiation treatment end hospitalization ACS ( possibly reperfusion stabilization cardiac medication )</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Patient Aged 18 year old Patient Depressive without antidepressant therapy three month ( valid sertraline placebo group ) Patient With ACS elevate cardiac enzyme ( 99th percentile upper limit normal laboratory ) Patient That assess depressive symptom : Test Beck ( 13 item ) Patient Affiliated social security scheme ( beneficiary assignee ) Patient Having sign free informed consent Cardiovascular History serious bleeding ( recent hemoglobin fall 5g / dl ( &lt; 3 month ) , intracranial hemorrhage hemorrhagic tamponade ) Uncontrolled hypertension ( SBP &gt; 180 mmHg DBP &gt; 100 mmHg ) Stroke &lt; 3 month Treatment ticagrelor prasugrel duration study . Psychiatric Psychosis , bipolar illness Dementia ( Mini Mental State Examination score &lt; 23 ) Uncontrolled epilepsy Severe depression ( score &gt; 15 ) suicidal risk identify psychiatrist ( urgent treatment depression need ) Patient experience depression treat last three month currently receive treatment Treatment selective nonselective monoamine oxidase inhibitor group A within 14 day prior introduction sertraline Clinical Biological Prothrombin time &gt; 1.5 second Platelet rate &lt; 100 000 / mm3 Hematocrit rate &lt; 25 % Serum creatinine &gt; 4.0 mg / dl Severe hepatic impairment ( Child Pugh stage C ) Contraindications sertraline ( placebo / sertraline group ) Hypersensitivity active substance excipients ( anhydrous lactose , pregelatinized corn starch , sodium laurilsulfate , magnesium stearate ) Treatment pimozide Genetic galactose intolerance , malabsorption glucose galactose , lactase deficiency Regulatory Women without effective contraception pregnant lactate desire pregnancy within 6 month randomization Participation biomedical research drug period participation Patients unable follow treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Acute Coronary Syndrome</keyword>
	<keyword>Depression</keyword>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Myocardial Infarction</keyword>
	<keyword>Percutaneous Coronary Intervention</keyword>
</DOC>